Speaker illustration

Professor Jong-Chan Youn

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul (Korea (Republic of))

Member of:

Heart Failure Association

Dr. Jong-Chan Youn is a Professor at Seoul St. Mary's Hospital and earned his medical degree and Ph.D. from Yonsei University College of Medicine. He conducted cardiovascular immunology and senescent T cell research as a postdoctoral researcher at KAIST's Immunology Lab. Dr. Youn's clinical expertise covers hypertension, dyslipidemia, and advanced heart failure, and he has published over 60 peer-reviewed articles in prestigious journals. He is an Assistant Editor of the 'Korean Circulation Journal' and an Associate Editor of the 'International Journal of Heart Failure'. Dr. Youn is an active member of several academic societies, including the Korean Society of Cardiology and the International Society for Heart and Lung Transplantation. He has received research grants as a principal investigator from various academic societies and the Korean Ministry of Science, ICT & Future Planning.

A budget impact analysis of empagliflozin for heart failure patients with full spectrum of ejection fraction in South Korea

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 6

Thumbnail

Cost-utility analysis and eligibility of dapagliflozin for patients with heart failure across the whole spectrum of ejection fraction

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 5

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb